Lexpos News

/Lexpos News

C-19 vac: Setting up FDP access

Pharmacy owners taking part in the spring COVID-19 vaccination programme will require Federated Data Platform (FDP) access to order COVID-19 vaccines. Pharmacy owners can request FDP access here. A step-by-step guide is also available. If access issues occur, pharmacy owners should clear their browser cache, switch to Microsoft Edge or use an InPrivate/Incognito window and [...]

The post C-19 vac: Setting up FDP access appeared first on Community Pharmacy England.

By |February 6th, 2026|Lexpos News|Comments Off on C-19 vac: Setting up FDP access

Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the January 2026 concessionary price for Rosuvastatin 10mg tablets and Trimethoprim 100mg tablets: Drug Pack size Price concession Rosuvastatin 10mg tablets 28 £4.48 (previously £2.70) Trimethoprim 100mg tablets 28 £4.08 (previously £3.77) [...]

The post Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026 appeared first on Community Pharmacy England.

By |February 6th, 2026|Lexpos News|Comments Off on Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026

MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight management and cardiovascular risk reduction. Patients reporting a sudden loss of vision (including partial loss) while [...]

The post MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) appeared first on Community Pharmacy England.

By |February 5th, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Rolled over price concessions for February 2026

The following price concessions granted in January 2026 have rolled over to February 2026: Drug Pack size January 2026 price concession Captopril 12.5mg tablets 56 £27.95 Captopril 25mg tablets 56 £25.95 Captopril 50mg tablets 56 £26.95 Codeine 15mg/5ml linctus sugar free 200 £17.34 Fusidic acid 1% modified-release eye drops 5 £35.00 Pyridoxine 10mg tablets 28 [...]

The post Rolled over price concessions for February 2026 appeared first on Community Pharmacy England.

By |February 5th, 2026|Lexpos News|Comments Off on Rolled over price concessions for February 2026

MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd)

MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) Drug Alert Number: EL(26)A/07 Date issued: 04 February 2026 Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters. DMRC reference [...]

The post MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) appeared first on Community Pharmacy England.

By |February 4th, 2026|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd)